Neurosearch A/S Closes the Sale of Huntexil® to Teva Pharmaceutical Industries Limited and Adjusts the Expectations to the Full-Year Result

Published: Oct 25, 2012

Today, NeuroSearch A/S (OMX: NEUR) closed the asset transfer agreement with Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) concerning the sale of the Huntexil® project to Teva as described in announcement no. 21-12 of 27 September 2012. The agreement was approved by NeuroSearch shareholders at the Extraordinary General Meeting, which was held on 23 October 2012.

Back to news